---
title: "Inflection Point  Acquisition - Unit | 10-K: FY2025 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283984640.md"
datetime: "2026-04-24T10:50:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283984640.md)
  - [en](https://longbridge.com/en/news/283984640.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283984640.md)
---

# Inflection Point  Acquisition - Unit | 10-K: FY2025 Revenue: USD 0

Revenue: As of FY2025, the actual value is USD 0.

EPS: As of FY2025, the actual value is USD 0.04.

EBIT: As of FY2025, the actual value is USD -5.819 M.

#### Overview

INFLECTION POINT ACQUISITION CORP. V (f/k/a MAYWOOD ACQUISITION CORP.) is a blank check company with no operating revenues, generating non-operating income primarily from interest earned on funds held in its Trust Account.

#### Operational Metrics

-   **Net Income (Loss)**: For the year ended December 31, 2025, the company reported a net income of $396,872, a significant increase from the net loss of - $7,712 incurred for the period from May 31, 2024 (inception) to December 31, 2024.
-   **Operating Costs**: Formation and operating costs were $2,717,289 for the year ended December 31, 2025, compared to $7,681 for the period from May 31, 2024, to December 31, 2024.
-   **Interest Income**: Interest earned on marketable securities held in the Trust Account amounted to $3,089,290 for the year ended December 31, 2025. Additionally, interest income was $12,369 for the same period.
-   **Forgiveness of Debt**: The company recorded $12,502 in forgiveness of debt for the year ended December 31, 2025, due to the termination of the Administrative Services Agreement.

#### Cash Flow

-   **Net Cash Used in Operating Activities**: Net cash used in operating activities was - $701,278 for the year ended December 31, 2025, compared to $106,602 for the period from May 31, 2024 (inception) to December 31, 2024.
-   **Net Cash Used in Investing Activities**: The company used - $86,250,000 in investing activities for the year ended December 31, 2025, primarily due to cash deposited into the Trust Account.
-   **Net Cash Provided by Financing Activities**: Net cash provided by financing activities was $86,977,023 for the year ended December 31, 2025, and - $106,602 for the period from May 31, 2024, to December 31, 2024.

#### Unique Metrics

-   **Cash in Operating Bank Account**: As of December 31, 2025, the company had $25,745 in its operating bank account.
-   **Working Capital Deficit**: As of December 31, 2025, the company had a working capital deficit of - $2,079,709.
-   **Funds in Trust Account**: Approximately $89,330,468.24 was held in the Trust Account as of December 31, 2025.
-   **Deferred Underwriting Fee**: A deferred underwriting fee of $3,450,000 is payable upon the successful completion of a business combination.
-   **Sponsor Loan**: A non-interest-bearing Sponsor Loan of $500,000 was provided by the Prior Sponsor and later assigned to the New Sponsor. On January 7, 2026, this loan was amended to $700,000 to reflect an additional $200,000 advance for working capital.

#### Outlook / Guidance

Management has identified a substantial doubt about the company’s ability to continue as a going concern due to its liquidity position. The company faces mandatory liquidation if a business combination is not completed by August 14, 2026. To avoid liquidation, the company intends to consummate the proposed GOWell Business Combination before this deadline.

### Related Stocks

- [IPEXU.US](https://longbridge.com/en/quote/IPEXU.US.md)

## Related News & Research

- [Dear Future SpaceX (SPCX) Stock Fans, Mark Your Calendars for June 12](https://longbridge.com/en/news/286809659.md)
- [Yext to Announce First Quarter Fiscal Year 2027 Financial Results on June 2, 2026 | YEXT Stock News](https://longbridge.com/en/news/286970613.md)
- [Home Depot Was Once My Greatest Investment, But Now It's a Flaming Mess](https://longbridge.com/en/news/286951517.md)
- [Is Nvidia spending its cash on the right things? Investors will soon get an update.](https://longbridge.com/en/news/286948142.md)
- [Eli Lilly Retatrutide 12 Mg Achieved 30.3% Average Weight Loss At 104 Weeks In Extension](https://longbridge.com/en/news/287203984.md)